Instability of protein drugs;Instabilitäten von proteinarzneimitteln

PZ Prisma

Volumn 10, Issue 1, 2003, Pages 15-18

  Schumacher, Katrin ^b   Winter, Gerhard ^b   Mahler, Hanns Christian ^a  

^a MERCK KGAA   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ANTIBODY; CALCITONIN; CYTOKINE; ENZYME; ERYTHROPOIETIN; GLUCAGON; GLUCOSYLCERAMIDASE; HORMONE; INFLIXIMAB; INTERFERON; INTERLEUKIN 2; PEPTIDE; PROTEIN; SOMATOSTATIN; TUMOR NECROSIS FACTOR ALPHA;

ADSORPTION; ARTICLE; DEAMINATION; DISULFIDE BOND; DRUG ACTIVITY; DRUG HYDROLYSIS; DRUG OXIDATION; DRUG STABILITY; ENZYME DEFICIENCY; FABRY DISEASE; HORMONE DEFICIENCY; MACROMOLECULE; PRECIPITATION; PROTEIN DENATURATION;

EID: 0037285553     PISSN: 09455566     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Allison, S. D.; Chang, B. S.; Randolph, T. W.; Carpenter, J. F.: Hydrogen bonding between sugar and protein is responsible for inhibition of dehydration-induced protein unfolding. Arch. Biochem. Biophys. 365, 289-298 (1999)
2. Brange, J.: Physical Stability of Proteins. In S. Frokjaer and L. Hovgaard, editors, Pharmaceutical Formulation Development of Peptides and Proteins. Taylor & Francis. Philadelphia 2000. S. 89-112
3. Carpenter, J. F., Arakawa, T.; Crowe, J. H.: Interactions of stabilizing additives with proteins during freeze-thawing and freeze-drying. Dev. Biol. Stand. 74, 225-239 (1990)
4. Carpenter, J. F., Kendrick, B. S.; Chang, B. S.; Manning, M. C.; Randolph, T.W.: Inhibition of stress-induced aggregation of protein therapeutics. Meth. Enzymol. 309, 236-255 (1999)
5. Cleland, J. L., Powell, M. F.; Shire, S. J.: The development of stable protein formulations: A close look at protein aggregation, deamidation, and oxidation. Crit. Rev. Ther. Drug Carrier Syst. 10, 307-377 (1993)
6. Hora, M. S., Rana, R. K.; Wilcox, C. L.; Katre, N. V.; Hirtzer, P.; Wolfe, S. N.; Thomson, J. W.: Development of a lyophilized formulation of interleukin-2. Dev. Biol. Stand. 74, 295-306 (1992)
7. Lai, M. C.; Topp, E.M.: Solid-state chemical stability of proteins and peptides. J. Pharm. Sci. 88, 489-500 (1999)
8. Manning, M. C., Patel, K.; Borchardt, R. T.: Stability of protein pharmaceuticals. Pharm. Res. 6, 903-918 (1989)
9. Scheelekens, H.: Bioequivalence and the immunogenicity of biopharmaceuticals. Nature Reviews Drug Discovery 1, 457-462(2002)
10. Wang, W.: Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int. J. Pharm. 185, 129-188 (1999)
11. Wong, D.; Parasrampuria, J.:Pharmaceutical excipients for the stabilization of proteins. BioPharm 10, 52-60 (1997)
12. Informationssekretariat Biotechnologie; http://www.i-s-b.org/zahlen.htm